Congratulations to all researchers from Lund Stem Cell Center awarded support from Cancerfonden!
Researchers awarded project grants include:
Henrik Ahlenius - ‘Modeling and intervention in glioma using stem cells, reprogramming and genome engineering.’
Link to the Ahlenius research group
Tariq Enver - ‘Delineating the transcriptional and cellular context of leukaemic initiation and progression in childhood acute lymphoblastic leukaemia using a human induced pluripotent stem cell model of foetal lymphopoiesis.’
Link to the Enver research group
Mattias Magnusson - ‘Resolving treatment resistance in human non-small cell lung cancer.’
Link to the Magnusson research group
Björn Nilsson - ‘Genetic variation influencing blood cancer risk and blood stem cell activity.’
Link to the Nilsson research group
Filipe Pereira - 'Understanding dendritic cell diversity with cell reprogramming.'
Link to the Pereira research group
Stefan Scheding - 'A xenotransplantation model of fibrosis in myeloproliferative neoplasms to develop novel therapies targeting specific fibrosis-driving pathways.'
Link to the Scheding research group
Mikael Sigvardsson - 'Oncogenic conversion of transcription factor networks as a driving force in B-lymphocyte transformation.'
Link to the Sigvardsson research group
Niels-Bjarne Woods - de novo generation of transplantable hematopoietic stem cells from pluripotent stem cells.
Link to the Woods research group
Joan Yuan - 'On how neonatal determinants influence the incidence of B cell malignancies later in life.'
Link to the Yuan research group
Researchers awarded continued support:
Björn Nilsson - 'Development of PPM1H inhibitors to facilitate stem cell harvesting.'
For more details of funding follow this link:
Cancerfonden grant announcements 2020